Article Text

Download PDFPDF
Idylla microsatellite instability assay versus mismatch repair immunohistochemistry: a retrospective comparison in gastric adenocarcinoma
  1. Luke Farmkiss1,
  2. Ilona Hopkins2,
  3. Mary Jones2
  1. 1Histopathology Department, Plymouth Hospitals NHS Foundation Trust, Plymouth, UK
  2. 2Department of Diagnostic and Molecular Pathology, Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK
  1. Correspondence to Dr Luke Farmkiss, Histopathology Department, Plymouth Hospitals NHS Foundation Trust, Plymouth PL6 8DH, UK; luke.farmkiss{at}nhs.net

Abstract

Up to 22% of all gastric adenocarcinomas are of the microsatellite instability (MSI) subtype. This subtype may not benefit from conventional adjuvant chemotherapy but does respond to novel immunotherapies. A proportion of MSI gastric adenocarcinomas are associated with inherited disease, inferring an opportunity to screen for further cancers in the patient while also identifying at-risk relatives. Although the importance of MSI subtyping is clear, the methods of detection vary. The main techniques are MSI testing and mismatch repair (MMR) immunohistochemistry (IHC). This study compares a novel Idylla (Biocartis) MSI assay to MMR IHC across 50 biopsies of gastric adenocarcinoma. The methods were concordant across 48 cases. The two discrepant results demonstrated known difficulties in the interpretation of IHC. Idylla MSI testing presents several advantages over MMR IHC but both methods are well established in detecting this subtype of gastric adenocarcinoma. The methods are best regarded as complementary tests, performing most optimally when combined.

  • gastrointestinal neoplasms
  • pathology
  • molecular
  • diagnostic techniques and procedures
  • stomach neoplasms
  • immunohistochemistry
View Full Text

Statistics from Altmetric.com

Footnotes

  • Handling editor Runjan Chetty.

  • Twitter @LFarmery

  • Contributors Dr Adam Pollard performed statistical analysis. Mr Russell Hill provided laboratory assistance.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Idylla MSI assay equipment and cartridge supplies were provided by Idylla Biocartis.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.